Stockreport

Tempus AI Highlights Strong Growth At The J.P. Morgan Healthcare Conference [Seeking Alpha]

Tempus AI, Inc. - Class A  (TEM) 
PDF TEM is guided to $1.59B revenue and $65M adjusted EBITDA in 2026, outpacing analyst expectations and de-risking the investment case. Diagnostics segment shows strong [Read more]